Please login to the form below

Not currently logged in
Email:
Password:

emerging markets

This page shows the latest emerging markets news and features for those working in and with pharma, biotech and healthcare.

Sanofi sells European generics to Advent for $2.4bn

Sanofi sells European generics to Advent for $2.4bn

Sanofi’s total generics sales fell 3.3% to 1.78bn last year, with the declines most apparent in Europe and emerging markets.

Latest news

  • Sanofi backs vaccines unit with €350m Canadian facility Sanofi backs vaccines unit with €350m Canadian facility

    by the timing of tenders in emerging markets.

  • Novartis doubles down on biosimilars with Biocon alliance Novartis doubles down on biosimilars with Biocon alliance

    Already a big player in the emerging biosimilars market, Novartis has struck a deal with India’s Biocon in a bid to extend its position. ... and trastuzumab drugs in some emerging markets.

  • The new basics The new basics

    At the moment, these are most salient in emerging markets but it may prove a good reputational investment to extend the same access programmes to the poor of advanced economies. ... Its social and technological environments have changed and are changing

  • AZ pushes harder into China with new joint venture AZ pushes harder into China with new joint venture

    AZ has included growth in emerging markets - and particularly China - as a key strategic priority for several years, naming the country as one of its pillars for future growth when chief ... Sales in emerging markets - led by China - rose 9% to $1.52bn

  • AZ CEO says company’s renaissance is on track AZ CEO says company’s renaissance is on track

    Rising sales of new cancer drug Tagrisso, a lower impact from patent losses and strong performance in emerging markets show that AstraZeneca’s turnaround plan is on course, according to its ... Sales in emerging markets - led by China - rose 9% to

More from news
Approximately 21 fully matching, plus 399 partially matching documents found.

Latest Intelligence

  • Is trust in healthcare improving? Is trust in healthcare improving?

    This is a trend observed across sectors and institutions - emerging markets are more trusting as they are more open to progress and the improvements that healthcare can bring. ... And greater levels of trust amongst the young and in emerging markets are

  • Waking the sleeping giant Waking the sleeping giant

    in South Africa, Africa and many emerging markets for almost two decades.

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    An aging population, along with a growing determination to improve access to healthcare in both developed and emerging markets, is placing renewed pressure on already-stretched health budgets.

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    An aging population, along with a growing determination to improve access to healthcare in both developed and emerging markets, is placing renewed pressure on already-stretched health budgets.

  • Adding value in emerging markets Adding value in emerging markets

    a branded version of ibuprofen. Branded generics are very popular in emerging markets. ... Providing affordable, trusted and differentiated products. Branded generics are an important driver in emerging markets.

More from intelligence
Approximately 14 fully matching, plus 57 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 55 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics